Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.950
-0.080 (-7.72%)
Nov 21, 2024, 10:59 AM EST - Market open
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $265.29 million as of November 21, 2024. Its market cap has decreased by -53.19% in one year.
Market Cap
265.29M
Enterprise Value
-114.49M
1-Year Change
-53.19%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $265.29M, a decrease of -93.57%. That is a compound annual growth rate of -55.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 287.60M | -41.14% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 314.88M |
| Alpha Teknova | 314.55M |
| Lexicon Pharmaceuticals | 314.53M |
| Cerus | 312.00M |
| Absci | 308.96M |
| ClearPoint Neuro | 305.50M |
| Aclaris Therapeutics | 305.07M |
| Sanara MedTech | 302.75M |